drugset / Trial / NCT03960606
Study in Adult Asthmatic Patients With Allergic Bronchopulmonary Aspergillosis
RandomizedParallel-groupTriple-blindTreatment
Summary
A Randomized, Double-Blind, Multicenter, Placebo-Controlled, Phase 2 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Itraconazole Administered as a Dry Powder for Inhalation (PUR1900) in Adult Asthmatic Patients With Allergic Bronchopulmonary Aspergillosis
Timeline
- Start
- 2019-07-31
- Primary completion
- 2020-07-14
- Completion
- 2020-07-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Itraconazole | Small molecule | 10 mg | Oral |
| Subject | Itraconazole | Small molecule | 20 mg | Oral |
| Subject | Itraconazole | Small molecule | 35 mg | Oral |